Stockscreener 앱 받기
2.815
3.60%
-0.105
시간 외 거래:
2.82
0.005
+0.18%
Akoya Biosciences Inc 주식(AKYA)의 최신 뉴스
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Significant Decrease in Short Interest - MarketBeat
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024 - StockTitan
BTIG Downgrades Akoya Biosciences (AKYA) - MSN
Layoff Tracker: Marinus Cuts Employees After Disappointing Phase III Trial - BioSpace
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives $6.56 Consensus Price Target from Brokerages - MarketBeat
Akoya Biosciences (AKYA) Stock Price, News & Analysis - MarketBeat
Akoya Biosciences Inc (AKYA) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock Rockets 36% But Many Are Still Ignoring The Company - Simply Wall St
Akoya Biosciences joins UK cancer research initiative By Investing.com - Investing.com South Africa
Akoya Biosciences joins UK cancer research initiative - Investing.com India
Akoya’s Leading Spatial Proteomics Platforms Selected for - GlobeNewswire
Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy - The Manila Times
Akoya's Leading Spatial Proteomics Platforms Selected for Use by Uk-Based Manifest Consortium to Revolutionize Cancer Immunotherapy - Marketscreener.com
IPO Alert: Akoya Biosciences - RTTNews
Akoya Biosciences appoints new chairman By Investing.com - Investing.com South Africa
Akoya Biosciences Appoints Scott Mendel as Chairman of the Board of Directors - citybiz
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors - ForexTV.com
Akoya Biosciences appoints new chairman - Investing.com
Akoya Biosciences names Scott Mendel as new board chairman By Investing.com - Investing.com Australia
Akoya Biosciences names Scott Mendel as new board chairman - Investing.com
Spatial Proteomics Market Size, Share, Growth Report, 2030 - Grand View Research
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Large Decline in Short Interest - MarketBeat
Wall Street SWOT: Akoya Biosciences stock faces headwinds amid spatial proteomics growth By Investing.com - Investing.com South Africa
Wall Street SWOT: Akoya Biosciences stock faces headwinds amid spatial proteomics growth - Investing.com
Caxton Associates LP Takes $2.23 Million Position in American International Group, Inc. (NYSE:AIG) - Defense World
Global Spatial Omics Market Projected to Reach $ 424.2 Million by 2032, Growing at 10.5% CAGR - 대구포스트
Brokerages Set Akoya Biosciences, Inc. (NASDAQ:AKYA) Target Price at $6.56 - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Immunohistochemistry IHC Market Advancements Highlighted by Size, Share Analysis, Trends And Forecast 2024-... - WhaTech
Piper Sandler Maintains Akoya Biosciences (AKYA) Overweight Recommendation - MSN
Akoya Biosciences, Inc.'s (NASDAQ:AKYA) biggest owners are private equity firms who got richer after stock soared 18% last week - Simply Wall St
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 6.3% in August - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Spatial OMICS Market Size, Growth Analysis | CAGR of 10.7% - Market.us
Europe, CIS & Africa Spatial Transcriptomics (Instruments, Consumables) Market Size, Share & Trends Analysis Report 2024-2030 - GlobeNewswire Inc.
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Large Growth in Short Interest - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Large Increase in Short Interest - MarketBeat
Vanguard Group Inc. Has $6.82 Million Stock Position in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences (NASDAQ:AKYA) Price Target Lowered to $4.00 at Piper Sandler - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target - Simply Wall St
FY2024 EPS Estimates for Akoya Biosciences, Inc. Raised by Capital One Financial (NASDAQ:AKYA) - MarketBeat
Capital One Financial Research Analysts Boost Earnings Estimates for Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint - Yahoo Finance
Closing Figures: Akoya Biosciences Inc (AKYA)’s Negative Finish at 2.01, Down -6.51 - The Dwinnex
Insiders Give Up US$52k As Akoya Biosciences Stock Drops To US$2.01 - Simply Wall St
JP Morgan Downgrades Akoya Biosciences (AKYA) - MSN
Akoya Biosciences (NASDAQ:AKYA) Price Target Lowered to $7.00 at Craig Hallum - Defense World
Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $7.00 by Analysts at Craig Hallum - MarketBeat
Akoya Biosciences (NASDAQ:AKYA) Releases Quarterly Earnings Results, Hits Expectations - MarketBeat
Morgan Stanley cuts Akoya Biosciences rating on capital spend concerns - Investing.com
Akoya Biosciences (NASDAQ:AKYA) Cut to “Equal Weight” at Morgan Stanley - Defense World
A Closer Look at 4 Analyst Recommendations For Akoya Biosciences - Benzinga
BTIG cuts Akoya Biosciences stock rating amid revenue, staff concerns By Investing.com - Investing.com Australia
Akoya Biosciences (NASDAQ:AKYA) Issues Quarterly Earnings Results - Defense World
JPMorgan Chase & Co. Lowers Akoya Biosciences (NASDAQ:AKYA) to Neutral - American Banking and Market News
0.40%
자본화:
|
볼륨(24시간):